Results 41 to 50 of about 2,249,117 (300)
Frontiers in Medicine, 2022 PurposeTo compare the efficacies and treatment outcomes of intravitreal anti-VEGF agents and laser therapy in retinopathy of prematurity (ROP).MethodsA retrospective, non-randomized, comparative study of patients diagnosed with type 1 ROP or aggressive ...
Dandan Linghu +27 more
doaj +1 more source
Mechanisms of vascular morphogenesis and stabilization by VEGF dose [PDF]
, 2014 VEGF is the master regulator of angiogenesis and the most investigated factor in therapeutic angiogenesis approaches to induce the growth of new vessels that could restore oxygen and nutrients supply in tissues affected by ischemia.
Groppa, Elena
core +1 more source
Predictive biomarkers of age-related macular degeneration response to anti-VEGF treatment [PDF]
, 2021 Age-related macular degeneration (AMD) is an incurable disease associated with aging that destroys sharp and central vision. Increasing evidence implicates both systemic and local inflammation in the pathogenesis of AMD.
Ochoa, Rodrigo +13 more
core +1 more source
Anti-VEGF Therapy and the Retina: An Update [PDF]
Journal of Ophthalmology, 2015 Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a result of oedema, haemorrhage, and scarring.
Tah, V +7 more
openaire +4 more sources
Data of- QOL among patients on Anti-VEGF
, 2023 The present data set is of the study on Quality of Life and financial burden among patients receiving anti-VEGF ...
Dr Sanjay Kini B (15901601) +1 more
core +1 more source
Biomarkers as Predictive Factors of Anti-VEGF Response [PDF]
, 2022 Age-related macular degeneration is the main cause of irreversible vision in developed countries, and intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are the current gold standard treatment today.
Bobadilla, Miriam +14 more
core +1 more source
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia [PDF]
, 2003 Vascular endothelial growth factor (VEGF-A) is a major regulator of blood vessel formation and function. it controls several processes in endothelial cells, such as proliferation, survival, and migration, but it is not known how these are coordinately ...
Shima, D. +32 more
core +1 more source
Anti-Vascular Endothelial Growth Factor Antibody Suppresses ERK and NF-κB Activation in Ischemia-Reperfusion Lung Injury. [PDF]
PLoS ONE, 2016 Ischemia-reperfusion (IR)-induced acute lung injury (ALI) is implicated in several clinical conditions like lung transplantation, acute pulmonary embolism after thrombolytic therapy, re-expansion of collapsed lung from pneumothorax or pleural effusion ...
Chou-Chin Lan +5 more
doaj +1 more source
BMJ Open Ophthalmology, 2022 Purpose To evaluate the efficacy and safety of antivascular endothelial growth factor (anti-VEGF) agents in treating macular oedema due to retinal vein occlusion (RVO-ME).Methods Studies of randomised controlled trials were searched in PubMed, EMBASE ...
Chao Zhang +3 more
doaj +1 more source
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice
Biomedicines, 2023 Neovascular age-related macular degeneration (nAMD) with choroidal neovascularization (CNV) is a leading cause of blindness in the elderly in developed countries.
Chengchi Huang +6 more
doaj +1 more source